跳至主要内容
临床试验/NL-OMON52228
NL-OMON52228招募中不适用

Additional effect of hydrolysed collagen/vitamin C in exercise treatment for Patellar Tendinopathy (Jumper*s knee); a randomized controlled trial - the JUMPFOOD study

Ziekenhuisvoorzieningen Gelderse Vallei0 个研究点目标入组 76 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
76

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
16 至 64(—)

入选标准

  • - Signed informed consent.
  • - Age 16 - 40 years old
  • - History of focal knee pain in patellar tendon or its patellar or tibial
  • insertion in association with training and/or competition.
  • - Current symptom duration of at least 12 weeks.
  • - Sports participation at least once a week for at least one year.
  • - Palpation tenderness to the corresponding painful area on the patellar tendon.
  • - Focal patellar tendon pain during patellar tendon loading pain provocation
  • test (single leg decline squat and/or single leg jump squat)
  • - Victorian Institute of Sports Assessment (VISA-P) score < 80 out of 100
  • - Willing to take (non-vegetarian) nutritional supplements.
  • - Willing and able to perform the PTLE program.

排除标准

  • - Known presence of inflammatory joint diseases (e.g. spondylarthropathy, gout
  • or rheumatoid arthritis) or familial hypercholesterolaemia.
  • - Signs or symptoms of other coexisting knee pathology on physical examination
  • (such as joint effusion and joint line tenderness) or additional diagnostics
  • (Chondral lesion of the patella or trochlea on MRI or prepatellar bursitis on
  • - Daily use of drugs with a putative effect on the patellar tendon in the
  • preceding year (e.g. fluoroquinolones and statins).
  • - Having had a patellar tendon surgery.
  • - Having had a knee surgery without full recovery.
  • - Previous patellar tendon rupture of the index knee.
  • - Local injection therapy with corticosteroids, other drugs, blood, platelet
  • rich plasma or stem cells in the preceding 12 months.
  • - Acute knee or patellar tendon injuries (other than PT).
  • - Participation in other concomitant treatment programs.
  • - Participation in other research projects during participation of the JUMPFOOD
  • - Already using (hydrolysed) collagen supplementation.
  • - Giving blood donation in a period of two months prior to each test day.
  • - Being pregnant or wish to become pregnant in the upcoming year.
  • - Alcohol consumption for men >21 units/week and >4/day; for women >14
  • units/week and >3/day.
  • - Abuse of hard drugs.

研究者

发起方
Ziekenhuisvoorzieningen Gelderse Vallei

相似试验

Additional effect of hydrolysed collagen/vitamin C... | 临床试验